Details of the Drug

General Information of Drug (ID: DMTH56Y)

• Drug Name: BT-016
• Synonyms: Tregalizumab

Indication

Disease Entry	ICD 11	Status	REF
Rheumatoid arthritis	FA20	Phase 2	[1]

• Cross-matching ID: TTD ID: D00PUT

References

• [1] ClinicalTrials.gov (NCT01999192) Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid Arthritis. U.S. National Institutes of Health.